Publication | Closed Access

The Efficacy and Safety of the Novel Aldosterone Antagonist Eplerenone in Children with Hypertension: A Randomized, Double-Blind, Dose-Response Study

Non-pharmacological InterventionHypertensionCardiovascular DiseaseMedicineAntihypertensive TherapyPediatricsCardiovascular PharmacologyPrimary AldosteronismDose-response StudyPharmacotherapyPharmacologyBlood PressureEndocrine Hypertension